Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lehr Martin A.
Chief Executive Officer at Context Therapeutics. Filing since 22 Oct 2021.
CIK 0001861989
Company
Date
Role
Action
Shares
Amount
Of holding
CNTX
Context Therapeutics Inc.
9 Jun 2025
Chief Executive Officer
Bought
100,000
$70.08K
12.2%
CNTX
Context Therapeutics Inc.
21 Feb 2023
Chief Executive Officer
Bought
5,823
$4.90K
3.8%
CNTX
Context Therapeutics Inc.
13 Feb 2023
Chief Executive Officer
Bought
5,606
$4.90K
3.8%
CNTX
Context Therapeutics Inc.
6 Feb 2023
Chief Executive Officer
Bought
5,040
$4.90K
3.5%
CNTX
Context Therapeutics Inc.
30 Jan 2023
Chief Executive Officer
Bought
7,027
$4.90K
5.2%
CNTX
Context Therapeutics Inc.
23 Jan 2023
Chief Executive Officer
Bought
6,839
$4.90K
5.3%
CNTX
Context Therapeutics Inc.
17 Jan 2023
Chief Executive Officer
Bought
6,783
$5.00K
5.5%
CNTX
Context Therapeutics Inc.
16 Dec 2022
Chief Executive Officer
Bought
20,000
$14.80K
19.5%
CNTX
Context Therapeutics Inc.
19 Aug 2022
Chief Executive Officer
Bought
13,000
$24.06K
14.5%
CNTX
Context Therapeutics Inc.
16 Dec 2021
Chief Executive Officer
Bought
13,000
$41.85K
1.6%
CNTX
Context Therapeutics Inc.
22 Oct 2021
Chief Executive Officer
Bought
10,000
$50.00K
11.2%
11 decisions on file.
